Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Nimenrix Co-administered with Cervarix and Boostrix in Females
NCT01755689Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2013
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of meningococcal group A, C, W135 and Y conjugate vaccine in meningococcal infection, sponsored by GSK. Started Jan 2013; status: completed.
02
Drugs
meningococcal group A, C, W135 and Y conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT01755689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755689.